March 17, 2020 / 4:47 PM / 17 days ago

BRIEF-Xspray Receives Notification Of Manufacturing Approval And Provides Update On Clinical Studies

March 17 (Reuters) - XSpray Pharma AB (publ):

* XSPRAY RECEIVES NOTIFICATION OF MANUFACTURING APPROVAL AND PROVIDES UPDATE ON CLINICAL STUDIES

* XSPRAY PHARMA AB (PUBL) - PRODUCTION PARTNER NERPHARMA RECEIVED APPROVAL FROM ITALIAN MEDICINES AGENCY FOR FULL-SCALE PRODUCTION FACILITY IN MILAN

* XSPRAY PHARMA AB (PUBL) - APPROVAL APPLIES TO CLINICAL TRIAL USE OFAMORPHOUS MATERIAL BASED ON COMPANY’S HYNAP TECHNOLOGY

* XSPRAY PHARMA AB (PUBL) - COVID-19 PANDEMIC MAY AFFECT START OF PIVOTAL CLINICAL BIOEQUIVALENCE STUDIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below